Investigating the role of scleral fibroblasts in refractive development and myopia
Project Number1F32EY035573-01A1
Former Number1F32EY035573-01
Contact PI/Project LeaderBENTLEY, MELISSA R
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
Abstract
Myopia or ‘nearsightedness’ is rapidly approaching pandemic levels worldwide. If left to the current trajectory,
it is predicted that half of the world will be myopic by 2050. It is critical we develop novel treatments to prevent
and treat the underlying causes of myopia rather than just correcting blurred vision caused by refractive error.
To do this, we need to understand refractive development programs at the cell and cell signaling levels. It is
known that refractive development intricately intertwines input from environmental visual stimuli, retinoscleral
signaling, and scleral remodeling. This proposal specifically focuses on the ultimate consequence of myopia,
scleral ECM remodeling by resident fibroblasts. I hypothesize that scleral fibroblasts follow a specific
developmental differentiation program that is disrupted following exposure to myopic stimuli, which results in
aberrant cellular signaling and responses. In aim one, I will use the mouse model to identify fibroblast
characteristics in eyes that successfully undergo refractive development resulting in no refractive error
(emmetropia). I will then directly compare the changes that occur in mice that have been exposed to myopic
stimuli. These myopigenesis models include lens-induced myopia (LIM), which uses a negatively powered
lens placed in the visual pathway to stimulate myopic eye growth. Furthermore, work from the Pardue and
Ethier labs has shown that feeding the biologically active metabolite of retinoic acid (RA) signaling, all-trans-
retinoic acid (atRA), to mice is sufficient to induce similar myopic changes in the sclera. This, paired with
data showing increases in RA metabolites in myopic retinas, suggests a role for RA signaling in driving
myopia. In aim two, I will determine the role of retinoic acid signaling in myopia. Independent of whether the
hypotheses laid out in the proposal are supported, the results of these studies will provide valuable
information to myopia and vision research communities. To perform these studies, I will need to develop
skills including measuring refractive error and axial length in vivo, performing imaging techniques such as
multiphoton microscopy techniques and RNA scope, and learning the background knowledge needed to do
research in an entirely new system, the eye. These skills will be critical as I pursue my long-term goal of
becoming an independent researcher at an academic institution.
Public Health Relevance Statement
Project Narrative
Myopia is rapidly approaching pandemic levels worldwide. The proposed studies will use wild-type conditions,
environmental (LIM), and pharmacological (atRA) myopia models to elucidate the role of scleral fibroblasts during
refractive development in mice. In doing so, I will provide valuable insight into mechanisms driving myopia
development that are downstream of retinal signaling, which is an ideal window for clinical intervention in myopia
prevention and treatment.
No Sub Projects information available for 1F32EY035573-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F32EY035573-01A1
Patents
No Patents information available for 1F32EY035573-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F32EY035573-01A1
Clinical Studies
No Clinical Studies information available for 1F32EY035573-01A1
News and More
Related News Releases
No news release information available for 1F32EY035573-01A1
History
No Historical information available for 1F32EY035573-01A1
Similar Projects
No Similar Projects information available for 1F32EY035573-01A1